Cargando…
The Use of Central Nervous System Active Drugs During Pregnancy
CNS-active drugs are used relatively often during pregnancy. Use during early pregnancy may increase the risk of a congenital malformation; use during the later part of pregnancy may be associated with preterm birth, intrauterine growth disturbances and neonatal morbidity. There is also a possibilit...
Autores principales: | Källén, Bengt, Borg, Natalia, Reis, Margareta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817603/ https://www.ncbi.nlm.nih.gov/pubmed/24275849 http://dx.doi.org/10.3390/ph6101221 |
Ejemplares similares
-
Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
por: Reis, Margareta, et al.
Publicado: (2013) -
The Problem of Confounding in Studies of the Effect of Maternal Drug Use on Pregnancy Outcome
por: Källén, Bengt
Publicado: (2012) -
Drugs in Central Nervous System Disorders
por: Perry, Bruce D.
Publicado: (1985) -
Pregnancy Ketonemia and Development of the Fetal Central Nervous System
por: Bronisz, Agata, et al.
Publicado: (2018) -
Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019)